No more plans to invest in Russia: Pfizer CEO
Pfizer CEO Albert Bourla says his company is not cutting ties with Russia entirely, as that nation's invasion of Ukraine is about to enter its third week.
Pfizer
Pfizer CEO on new book, vaccine hesitancy
Pfizer CEO Dr. Albert Bourla joins “CBS Mornings” to discuss vaccine hesitancy and talk about his new book "Moonshot," which chronicles the company's remarkable push to create a COVID-19 vaccine.
Behind the scenes of the Pfizer vaccine
Dr. Albert Bourla, the pharmaceutical giant's chairman and CEO, talks about vaccine hesitancy, COVID misinformation, and the development of his company's coronavirus vaccine, an effort he writes about in the book "Moonshot."
Inside the labs of Pfizer
Correspondent Alina Cho talks with Dr. Albert Bourla, the chairman and CEO of Pfizer, about the development of his company's coronavirus vaccine, an effort he writes about in the book "Moonshot: Inside Pfizer's Nine-Month Race to Make the Impossible Possible." They also discuss his feelings about COVID misinformation and vaccine hesitancy.
New hurdles for COVID shot for young kids
The U.S. Surgeon General said Friday he imagines a future when COVID-19 is treated like any other respiratory virus. But he did not put a timeline on when that might happen and noted there are still hurdles ahead. Michael George has the latest.
Kids under 5 could get COVID vaccine by March
The White House said it will be ready to distribute Pfizer's vaccine for young children as soon as it has authorization, which could be as soon as March. Nancy Chen has the latest.
Pfizer asks FDA to allow COVID-19 vaccine for kids under 5
Children under the age of 5 are the only group not yet eligible for vaccination — but that could change soon.
Pfizer asks FDA to authorize vaccine for kids under 5
Pfizer has asked the FDA for emergency use authorization for its COVID-19 vaccine for children under 5, who have so far been ineligible for the vaccines. Nikki Battiste has the latest.
Students protest for COVID safety amid Omicron
Scientists are tracking an offshoot of the Omicron variant known as BA.2 as Pfizer works on developing an Omicron-specific vaccine. Meanwhile, some students in Washington, D.C. staged a walkout to demand stronger COVID protections. CBS News' Natalie Brand has more.
Pfizer starting study of vaccine geared toward Omicron variant
The new U.S. study is enrolling up to 1,420 healthy adults, ages 18 to 55, to test the updated Omicron-based shots for use as a booster or for primary vaccinations
Pfizer targets Omicron variant
Pfizer and BioNTech are working on a trial to test a modified COVID-19 vaccine aimed at targeting the Omicron variant. Dr. William Schaffner, a professor of infectious diseases at Vanderbilt University Medical Center, joined CBS News to discuss the latest on the pandemic, including why the FDA has halted use of two monoclonal antibody treatments that don't work well against Omicron.
Gottlieb doesn't expect vaccine for kids under 5 before late March
Dr. Scott Gottlieb, the former FDA commissioner, says the FDA and Pfizer are "looking very closely at the data that's accrued to see if they can make a decision around this."
U.S. debuts site for free at-home COVID tests
Some hospitals are overwhelmed, facing an influx of COVID-19 patients. Meanwhile, Pfizer says that its oral pill is showing efficacy against Omicron in lab tests. Dr. Jen Caudle joins CBSN to break down some of the latest coronavirus headlines.
Pfizer: Vaccine targeting Omicron will be ready in March
Drugmaker expects to be able to develop new variant-specific vaccines in roughly 100 days as COVID-19 mutates.
COVID hospitalizations rise as Omicron spreads
Omicron's rapid spread is fueling a wave of new COVID-19 hospitalizations in the United States. More children are also being admitted to hospitals, according to CDC data. CBS News correspondent Janet Shamlian reports from Houston. Then Dr. Jeremy Faust, emergency physician at Brigham and Women's Hospital at Harvard Medical School, joins CBSN's Lilia Luciano to discuss the latest on the pandemic.
CDC endorses boosters for ages 12 and up
The CDC has expanded the eligibility for booster shots to Americans ages 12 and up the as the Omicron variant surges rapidly across the country. Dr. William Schaffner, professor of preventive medicine and member of the CDC's Advisory Committee on Immunization Practices, joins CBSN to discuss the latest.
CDC clarifies isolation guidelines
After facing backlash, the Centers for Disease Control and Prevention have clarified COVID-19 isolation recommendations, endorsing a five-day quarantine period and an optional test as well as shortening the time frame between the second Pfizer vaccine dose and the booster shot from six to five months. John Moore, a professor of microbiology and immunology at Weill Cornell Medical College, joins CBSN to discuss the latest coronavirus news.
U.S. tops one million daily COVID cases
More than one million new COVID cases were reported Monday, a new single-day record for the U.S. Hospitalizations and childhood infections are also setting pandemic records. Omar Villafranca reports.
How antiviral pills could alter the pandemic
The FDA has authorized Pfizer's COVID-19 antiviral pill for emergency use. Dr. Jodie Guest joins Elaine Quijano on CBSN's "Red & Blue" with more on the state of the pandemic.
U.S. doubling and accelerating order of Pfizer antiviral pills
President Biden announced the increase and acceleration of the order on Tuesday.
FDA approves booster shots for some kids
The Food and Drug Administration has authorized booster shots for kids ages 12 to 15 and immunocompromised children ages 5 to 11, in response to the Omicron variant, which is driving a surge of COVID-19 infections in the U.S. Dr. Dyan Hes, founder of Gramercy Pediatrics, joins CBSN to discuss the latest coronavirus headlines.
Millions return to school despite COVID surge
Despite surging COVID cases, millions of children returned to school after the holidays. Meanwhile on Monday, the FDA announced children as young as 12 can get a booster shot of the Pfizer vaccine, but it comes as more children are being hospitalized. Meg Oliver reports.
FDA authorizes booster for ages 12 to 15
As COVID-19 cases surge across the U.S. the FDA has authorized Pfizer booster shots for children ages 12 to 15. CBS News correspondent Meg Oliver reports on how schools are proceeding with their return to class. Then Dr. Rajeev Fernando, who specializes in global infectious diseases, joins CBSN to discuss the latest on the pandemic.
U.S. reaches record number new COVID cases
Nearly half a million new COVID-19 cases were recorded in the U.S. on Wednesday. That number from the CDC is the highest single-day tally since the start of the pandemic. CBS News correspondent Nancy Chen reports from New York City. Then Dr. Payal Patel, an infectious disease physician at the University of Michigan, joined CBSN's Elise Preston to discuss the latest on the nation's health crisis.
Israel testing fourth Pfizer COVID vaccine shot
The clinical trial involves 150 volunteers from the staff of a hospital near Tel Aviv who are at least four months removed from their third vaccine shot and have signs of waning antibodies.
Palestinian gunmen kill 6 people in attack on Jerusalem bus stop
Israeli officials say two gunmen opened fire on a Jerusalem bus stop, killing six people and leaving seven others in serious condition.
Trial begins today for man accused of Trump assassination attempt
Ryan Routh, 59, has pleaded not guilty to charges of attempting to assassinate Mr. Trump during the presidential campaign and will be representing himself at trial.
Who won MTV Video Music Awards for 2025? See the full winners list here
See the full list of winners and nominees for the 2025 MTV Video Music Awards.
After Trump's health funding cuts, states face tough budget decisions
The Trump administration has pushed a significant amount of health costs to states, whose budgets may already be strained by declining state tax revenues, a slowdown in pandemic spending, and economic uncertainty.
Justice Barrett on the Supreme Court's checks on Trump's power
In her first TV interview since joining the Supreme Court in 2020, Justice Amy Coney Barrett also discusses her vote in the 2022 Dobbs abortion case.
CBS News poll: On Trump deploying National Guard, divisions over impact on crime, rights
Trump's approval rating ticks back up; support for tariffs declines as some pull back buying.
South Korea says it reached deal for release of workers detained in Georgia ICE raid
South Korea says it reached a deal with the U.S. to release more than 300 South Koreans detained in an immigration enforcement raid at a Georgia Hyundai plant.
New Zealand father on the run almost 4 years with his kids shot dead by police
Tom Phillips, who evaded authorities with his three kids in remote New Zealand countryside for nearly four years was shot and killed by a police officer
Rick Davies, Supertramp lead singer and co-founder, dies at 81
Rick Davies, lead singer and co-founder of Supertramp, has died of cancer at 81, the British band says, calling him "the voice and pianist behind Supertramp's most iconic songs" who left "an indelible mark on rock music history."